SignatureFD’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

SignatureFD’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.1K	Hold	213	–	–	﹤0.01%	2365
2026 Q1	$16.9K	Hold	213	–	–	﹤0.01%	2279
2025 Q4	$17.5K	Hold	213	–	–	﹤0.01%	2181
2025 Q3	$14.9K	Hold	213	–	–	﹤0.01%	2242
2025 Q2	$13.7K	Hold	213	–	–	﹤0.01%	2217
2025 Q1	$13.5K	Hold	213	–	–	﹤0.01%	2247
2024 Q4	$14.2K	Hold	213	–	–	﹤0.01%	2229
2024 Q3	$14.9K	Hold	213	–	–	﹤0.01%	2178
2024 Q2	$13.8K	Hold	213	–	–	﹤0.01%	2136
2024 Q1	$13.8K	Hold	213	–	–	﹤0.01%	2185
2023 Q4	$14K	Hold	213	–	–	﹤0.01%	2098
2023 Q3	$12.1K	Hold	213	–	–	﹤0.01%	2101
2023 Q2	$13.1K	Hold	213	–	–	﹤0.01%	2121
2023 Q1	$13.4K	Hold	213	–	–	﹤0.01%	2079
2022 Q4	$13.5K	Hold	213	–	–	﹤0.01%	1993
2022 Q3	$13K	Hold	213	–	–	﹤0.01%	1951
2022 Q2	$12K	Hold	213	–	–	﹤0.01%	2040
2022 Q1	$13K	Hold	213	–	–	﹤0.01%	2046
2021 Q4	$15K	Hold	213	–	–	﹤0.01%	1923
2021 Q3	$16K	Hold	213	–	–	﹤0.01%	1862
2021 Q2	$16K	Hold	213	–	–	﹤0.01%	1814
2021 Q1	$16K	Hold	213	–	–	﹤0.01%	1659
2020 Q4	$15K	Hold	213	–	–	﹤0.01%	1559
2020 Q3	$12K	Hold	213	–	–	﹤0.01%	1579
2020 Q2	$12K	Hold	213	–	–	﹤0.01%	1502
2020 Q1	$10K	Hold	213	–	–	﹤0.01%	1481
2019 Q4	$12K	Hold	213	–	–	﹤0.01%	1421
2019 Q3	$10K	Hold	213	–	–	﹤0.01%	1440
2019 Q2	$11K	Hold	213	–	–	﹤0.01%	1394
2019 Q1	$12K	Hold	213	–	–	﹤0.01%	1358
2018 Q4	$10K	Hold	213	–	–	﹤0.01%	1359
2018 Q3	$13K	Hold	213	–	–	﹤0.01%	1315
2018 Q2	$12K	Hold	213	–	–	﹤0.01%	1338
2018 Q1	$10K	Buy	+213	New	+$10.9K	﹤0.01%	1248
2016 Q4	–	Sell	-213	Closed	-$9K	–	919
2016 Q3	$9K	Hold	213	–	–	﹤0.01%	1054
2016 Q2	$8K	Hold	213	–	–	﹤0.01%	972
2016 Q1	$8K	Buy	+213	New	+$8.28K	﹤0.01%	898

Other funds holding PBE

YIA

YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return

PIM

Penobscot Investment Management Boston, Massachusetts $1.46B AUM 32.32% 1-Year Est. Return

BEI

Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return

NDSI

Newman Dignan & Sheerar Inc Providence, Rhode Island $523M AUM 26.16% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return

IHL

Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

DAS

Dynamic Advisor Solutions Phoenix, Arizona $3.53B AUM 22.61% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

SignatureFD's PBE Position: Q2 2026 in Review

SignatureFD held its Invesco Biotechnology & Genome ETF (PBE) position steady in Q2 2026 at 213 shares worth $19.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2365.

SignatureFD first reported a position in PBE in Q1 2016 and has held it in 37 quarters since. 23 funds tracked by Wall St. Rank hold PBE as of Q2 2026.

SignatureFD held 213 shares of Invesco Biotechnology & Genome ETF worth $19.1K as of Q2 2026.
SignatureFD left its Invesco Biotechnology & Genome ETF share count unchanged in Q2 2026.
Invesco Biotechnology & Genome ETF made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2365 holding.
SignatureFD first reported a position in Invesco Biotechnology & Genome ETF in Q1 2016 and has held it in 37 quarters since.
23 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.